Prognostic indexes in follicular lymphoma: A comparison of different prognostic systems

Annals of Oncology

Volumn 16, Issue 9, 2005, Pages 1508-1513

  Perea, G ^a   Altes A ^a   Montoto, S ^b   Lopez Guillermo A ^b   Domingo Domenech E ^c   Fernandez Sevilla A ^c   Ribera, J M ^d   Grau, J ^d   Pedro, C ^e   Angel Hernandez J ^f   Estany, C ^g   Briones, J ^a   Martino, R ^a   Sureda, A ^a   Sierra, J ^a   Montserrat, E ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f HOSPITAL DE MATARÓ   (Spain)

^g HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Follicular lymphoma; Prognostic index; Survival

Indexed keywords

ANTHRACYCLINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE DRUG DOSE; SURVIVAL RATE;

EID: 24044531302     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi269     Document Type: Article

References (30)

1. Armitage JO, Weisenburger DD, for the Non Hodgkin's Lymphoma Classification Project. New approach to classify non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. J Clin Oncol 1998; 16: 2780-2795.
2. Decaudin D, Lepage E, Brousse N et al. Low-grade stage III-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients - A study of the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1999; 17: 2499-2505.
3. Bierman PJ, Vose JM, Anderson JR et al. High dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445-450.
4. McLaughlin P, Hagemeister FB, Romaguera JE et al. Fludarabine, mitoxantrone and dexamethasone: An effective new regimen for indolent lymphomas. J Clin Oncol 1996; 14: 1262.
5. López R, Martino R, Sureda A et al. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience. Haematologica 1999; 84: 350-355.
6. Mahé B, Milpied N, Mellerin MP et al. PCR detection of residual Bcl-2/ IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma. Bone Marrow Transplant 2003; 31: 467-473.
7. Seymour JF, Pro B, Fuller LM et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. J Clin Oncol 2003; 21: 2115-2122.
8. Leonard RCF, Hayward RL, Prescott RJ, Wang JX. The identification of discrete prognostic groups in low-grade non-Hodgkin's lymphoma. Ann Oncol 1991; 2: 655-667.
9. Romaguera JE, McLaughlin P, North L et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. J Clin Oncol 1991; 9: 762-769.
10. Cameron DA, Leonard RCF, Jian-Hua M, Prescott RJ. Identification of prognostic groups in follicular lymphoma. Leuk Lymph 1993; 10: 89-99.
11. The Non-Hodgkin's Lymphoma Prognostic Factors Project. Development of a predictive model for aggressive lymphoma: The International NHL Prognostic Factors Project. N Engl J Med; 329 1993; 987-994.
12. López-Guillermo A, Montserrat E, Bosch F et al. Applicability of the International Index for agressive lymphomas to patients with lowgrade lymphoma. J Clin Oncol 1994; 12: 1343-1348.
13. Foussard C, Desablens B, Sensebe L et al. Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAM Group, France. Ann Oncol 1997; 8 (Suppl 1): 49-52.
14. Federico M, Vitolo U, Zinzani PL et al. Prognosis of follicular lymphoma: A predictive model based on a retrospective analysis of 987 cases. Blood 2000; 95: 783-789.
15. Solal-Céligny P, Roy P, Colombat P et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265.
16. Maartense E, le Cessie S, Kluin-Nelemans HC et al. Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: Analysis from a population-based non-Hodgkin's lymphoma registry. Ann Oncol 2002; 13: 1275-1284.
17. Perea G, Altés A, Montoto S et al. International and Italian prognostic indices in follicular lymphoma. Haematologica 2003; 88: 649-653.
18. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244-1253.
19. López-Guillermo A, Montserrat E, Bosch F et al. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution. Leuk Lymphoma 1994; 15: 159-165.
20. Bastion Y, Berger F, Bryon PA et al. Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years. Ann Oncol 1991; 2 (Suppl 2): 123-129.
21. Coiffier B, Bastion Y, Berger F et al. Prognostic factors in follicular lymphomas. Semin Oncol 1993; 20 (Suppl 5): 89-95.
22. Litam P, Swan F, Cabanillas F et al. Prognostic value of serum β-2 microglobulin in low-grade lymphoma. Ann Intern Med 1991; 114: 855-860.
23. López-Guillermo A, Cabanillas F, McDonnell TI et al. Correlation of Bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 1999; 93: 3081-3087.
24. López-Guillermo A, Cabanillas F, McLaughlin P et al. Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series. Ann Oncol 2000; 11 (Suppl 1): 137-140.
25. Zhao WL, Daneshpouy ME, Mounier N et al. Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood 2004; 103: 695-697.
26. Bilalovic N, Kirsti Blystod A, Golouh R et al. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol 2004; 121: 34-42.
27. Akasaka T, Lossos IS, Levy R. BCL-6 gene translocation in follicular lymphoma: A harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1931-1932.
28. Viardot A, Möller P, Högel J et al. Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. J Clin Oncol 2002; 20: 4523-4530.
29. Tilly H, Rossi A, Stamatoullas A et al. Prognostic value of chromosomal aberrations in follicular lymphoma. Blood 1994; 84: 1043-1049.
30. Dave S, Wright G, Tan B et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159-5169.